LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-9.41 Cr | ₹-12 Cr | ₹-9.49 Cr | ₹7.35 Cr | ₹-6.17 Cr |
What is the latest Cash Flow from Investing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-9.41 Cr |
| Mar2025 | ₹-12 Cr |
| Mar2024 | ₹-9.49 Cr |
| Mar2023 | ₹7.35 Cr |
| Mar2022 | ₹-6.17 Cr |
How is Cash Flow from Investing Activities of LYKA LABS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-9.41 Cr | Negative | |
| Mar2025 | ₹-12 Cr | Negative | |
| Mar2024 | ₹-9.49 Cr | Negative | |
| Mar2023 | ₹7.35 Cr | Positive | |
| Mar2022 | ₹-6.17 Cr | - | |
Compare Cash Flow from Investing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹311.0 Cr | 4.4% | 18.6% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 4.4% |
18.6% |
-13.8% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses